Evidence map›Paper›PMID 25822788›Full record

ArticleNature2015

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.

Seth B Coffelt, Kelly Kersten, Chris W Doornebal, Jorieke Weiden, Kim Vrijland, Cheei-Sing Hau, Niels J M Verstegen, Metamia Ciampricotti, Lukas J A C Hawinkels, Jos Jonkers and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,084 papers.

0numbers the graph read from it
0cells of the map it votes in
1,084citing papers in PubMed
49.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,084 citing papers in PubMed, 1,675 citations in OpenAlex.

  1. Neutrophils in cancer.Nature reviews. Cancer · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. The immunology of human breast cancer.Nature reviews. Immunology · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. γδ T cells and cancer.The Journal of clinical investigation · 2026
    Review
  11. γδ T cells in colorectal and liver cancer.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,024 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Seth B CoffeltDivisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Kelly Kersten *Divisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Chris W Doornebal *Divisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Jorieke WeidenDivisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Kim VrijlandDivisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Cheei-Sing HauDivisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Niels J M VerstegenDivisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Metamia CiampricottiDivisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Lukas J A C HawinkelsDepartment of Molecular Cell Biology, Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics, Leiden University Medical Center, Leiden, 2300 RC, The Netherlands.
Jos JonkersMolecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Karin E de VisserDivisions of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
The Netherlands Cancer Institute · NLLeiden University Medical Center · NL

Funding

European Research Council 615300Worldwide Cancer Research 11-0677
6 · The paper itself

Abstract

Metastatic disease remains the primary cause of death for patients with breast cancer. The different steps of the metastatic cascade rely on reciprocal interactions between cancer cells and their microenvironment. Within this local microenvironment and in distant organs, immune cells and their mediators are known to facilitate metastasis formation. However, the precise contribution of tumour-induced systemic inflammation to metastasis and the mechanisms regulating systemic inflammation are poorly understood. Here we show that tumours maximize their chance of metastasizing by evoking a systemic inflammatory cascade in mouse models of spontaneous breast cancer metastasis. We mechanistically demonstrate that interleukin (IL)-1β elicits IL-17 expression from gamma delta (γδ) T cells, resulting in systemic, granulocyte colony-stimulating factor (G-CSF)-dependent expansion and polarization of neutrophils in mice bearing mammary tumours. Tumour-induced neutrophils acquire the ability to suppress cytotoxic T lymphocytes carrying the CD8 antigen, which limit the establishment of metastases. Neutralization of IL-17 or G-CSF and absence of γδ T cells prevents neutrophil accumulation and downregulates the T-cell-suppressive phenotype of neutrophils. Moreover, the absence of γδ T cells or neutrophils profoundly reduces pulmonary and lymph node metastases without influencing primary tumour progression. Our data indicate that targeting this novel cancer-cell-initiated domino effect within the immune system--the γδ T cell/IL-17/neutrophil axis--represents a new strategy to inhibit metastatic disease.

Indexed as

AnimalsBreast NeoplasmsCD8-Positive T-LymphocytesDisease Models, AnimalFemaleGranulocyte Colony-Stimulating FactorInterleukin-17Interleukin-1betaLungLung NeoplasmsLymphatic MetastasisLymphocyte ActivationMiceNeoplasm MetastasisNeutrophilsPhenotypeGranulocyte Colony-Stimulating FactorInterleukin-17Interleukin-1beta

Identifiers

PMID25822788
PMCPMC4475637
OpenAlexW2044748328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.